Xue-Ting Deng
发表
N. Xu,
Mingzheng Wu,
Xue-Ting Deng,
2016,
The Journal of Neuroscience.
Xue-Ting Deng,
Fei Wang,
Quan-peng Li,
2019,
Cancer Cell International.
Xue-Ting Deng,
Quan-peng Li,
Xianxiu Ge,
2019,
Journal of cellular and molecular medicine.
Xiaonan Li,
Xue-Ting Deng,
Nan Zhou,
2022,
Cell death discovery.
Liang Hu,
Wen-tao Liu,
Guangqin Zhang,
2016,
Pain.
Mingzheng Wu,
Xue-Ting Deng,
P-C Ma,
2021,
Aging and disease.
Fei Wang,
Wei Zhou,
Xue-Ting Deng,
2022,
Frontiers in Pharmacology.
Wei Zhou,
Guangqin Zhang,
Xue-Ting Deng,
2021
.
Xue-Ting Deng,
Quan-peng Li,
Xianxiu Ge,
2019,
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
Xue-Ting Deng,
Mengjing Li,
Q. You,
2020,
Cancer communications.
Fei Wang,
Lingyu Tang,
Xue-Ting Deng,
2017,
Oncotarget.
Xue-Ting Deng,
Fei Wang,
Quan-peng Li,
2020,
Cancer communications.
Wen-tao Liu,
Xue-Ting Deng,
Xue-Jun Song,
2017,
Pain medicine.
Fei Li,
Xuefeng Wu,
Liang Hu,
2015,
Anesthesiology.
Ni Wang,
Xue-Ting Deng,
Fei Wang,
2020,
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
Xue-Ting Deng,
Fei Wang,
Quan-peng Li,
2019,
Cancer Cell International.
Aprepitant inhibits the development and metastasis of gallbladder cancer via ROS and MAPK activation
Fei Wang,
Fan Zhou,
Wei Zhou,
2023,
BMC Cancer.